BridgeMD
New treatment option for Diabetes Mellitus, Type 2
Official title Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
ClinicalTrials.gov ID: NCT07270016
What this study is testing
- What it's testing
- The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 24
You may be able to join if
- Ages 16-24 years, any sex or gender
- Diagnosis of type 2 diabetes in childhood (younger than 18 years of age)
- English-speaking (app in English)
- Possession of personal smartphone that is compatible with FreeStyle Libre app
You likely can't join if
- Cognitive impairment or severe psychiatric conditions that could interfere with participation in behavioral intervention for diabetes self-management
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.